Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Aled Rees

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 20, 2010
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patientsWiebke Arlt, Debbie S Willis, Sarah H Wild, et al.
Eclinicalmedicine|January 19, 2026
Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and PlenadrenAlessandro Prete, Verena Theiler-Schwetz, Wiebke Arlt, et al.
Eclinicalmedicine|February 20, 2026
Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714]Alessandro Prete, Verena Theiler-Schwetz, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2014
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasiaLucia Gagliardi, Andreas W Schreiber, Christopher N Hahn, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal HyperplasiaDeborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Clinical Endocrinology|May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease ControlRichard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2020
CATS II Long-term Anthropometric and Metabolic Effects of Maternal Sub-optimal Thyroid Function in Offspring and MothersIlaria Muller, Peter N Taylor, Rhian M Daniel, et al.
Human Genetics|March 31, 2006
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and strokeMartin Horan, Vicky Newsway, Yasmin, et al.
European Journal of Endocrinology|January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasiaLea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With CabergolineWilliam M Drake, Craig E Stiles, John S Bevan, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|August 20, 2010
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patientsWiebke Arlt, Debbie S Willis, Sarah H Wild, et al.
Eclinicalmedicine|January 19, 2026
Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and PlenadrenAlessandro Prete, Verena Theiler-Schwetz, Wiebke Arlt, et al.
Eclinicalmedicine|February 20, 2026
Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714]Alessandro Prete, Verena Theiler-Schwetz, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2014
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasiaLucia Gagliardi, Andreas W Schreiber, Christopher N Hahn, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal HyperplasiaDeborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Clinical Endocrinology|May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease ControlRichard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2020
CATS II Long-term Anthropometric and Metabolic Effects of Maternal Sub-optimal Thyroid Function in Offspring and MothersIlaria Muller, Peter N Taylor, Rhian M Daniel, et al.
Human Genetics|March 31, 2006
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and strokeMartin Horan, Vicky Newsway, Yasmin, et al.
European Journal of Endocrinology|January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasiaLea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With CabergolineWilliam M Drake, Craig E Stiles, John S Bevan, et al.
Pageof 9